Who
Brett Sandercock
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, ResMed.
In numbers
- Trades disclosed
- 275
- Buys
- 0
- Sells
- 134
- Bought
- $0
- Sold
- $75.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Dec 2004
- Last trade
- 1 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Apr 2026filed 3 Apr 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $224K1,000 at $224.31 | filing |
| 1 Apr 2026filed 3 Apr 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $224K1,000 at $224.31 | filing |
| 2 Mar 2026filed 3 Mar 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $254K1,000 at $254.30 | filing |
| 2 Mar 2026filed 3 Mar 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $254K1,000 at $254.30 | filing |
| 2 Feb 2026filed 3 Feb 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $257K1,000 at $257.03 | filing |
| 2 Feb 2026filed 3 Feb 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $257K1,000 at $257.03 | filing |
| 2 Jan 2026filed 5 Jan 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $242K1,000 at $241.75 | filing |
| 2 Jan 2026filed 5 Jan 2026 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $242K1,000 at $241.75 | filing |
| 1 Dec 2025filed 2 Dec 2025 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $244K1,000 at $244.16 | filing |
| 20 Nov 2025filed 24 Nov 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code A | —2,710 at $0.00 | filing |
| 3 Nov 2025filed 4 Nov 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 3 Nov 2025filed 4 Nov 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $203K2,000 at $101.64 | filing |
| 3 Nov 2025filed 4 Nov 2025 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $743K3,000 at $247.54 | filing |
| 1 Oct 2025filed 3 Oct 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 1 Oct 2025filed 3 Oct 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $203K2,000 at $101.64 | filing |
| 1 Oct 2025filed 3 Oct 2025 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $823K3,000 at $274.36 | filing |
| 2 Sep 2025filed 3 Sep 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 2 Sep 2025filed 3 Sep 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $203K2,000 at $101.64 | filing |
| 2 Sep 2025filed 3 Sep 2025 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $812K3,000 at $270.77 | filing |
| 15 Aug 2025filed 19 Aug 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code A | —5,462 at $0.00 | filing |
News
Abbott Laboratories (NYSE:ABT) & ResMed (NYSE:RMD) Head to Head AnalysisRMD · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Brett Sandercock; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.